共 50 条
- [4] A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes DIABETES OBESITY & METABOLISM, 2011, 13 (05): : 426 - 433
- [9] LY2189265, a long-acting glucagon-like peptide-1 analogue, showed a dose-dependent effect on insulin secretion in healthy subjects DIABETES OBESITY & METABOLISM, 2011, 13 (05): : 434 - 438